Combining NK cells and mAb9.2.27 to combat NG2-dependent and anti-inflammatory signals in glioblastoma

類似資料

• Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival
  著者:: Poli, Aurélie, 等
  出版事項: (2013)
• Dynamic Contrast Enhanced MRI Detects Early Response to Adoptive NK Cellular Immunotherapy Targeting the NG2 Proteoglycan in a Rat Model of Glioblastoma
  著者:: Rygh, Cecilie Brekke, 等
  出版事項: (2014)
• NK Cells with KIR2DS2 Immunogenotype Have a Functional Activation Advantage To Efficiently Kill Glioblastoma and Prolong Animal Survival
  著者:: Gras Navarro, Andrea, 等
  出版事項: (2014)
• Pharmacokinetic mAb–mAb Interaction: Anti-VEGF mAb Decreases the Distribution of Anti-CEA mAb into Colorectal Tumor Xenografts
  著者:: Abuqayyas, Lubna, 等
  出版事項: (2012)
• Targeting the NG2/CSPG4 Proteoglycan Retards Tumour Growth and Angiogenesis in Preclinical Models of GBM and Melanoma
  著者:: Wang, Jian, 等
  出版事項: (2011)